Novo Nordisk CEO to Testify on High Prices of Ozempic, Wegovy
Senate subpoenas Novo's Langa over drug pricing; Jorgensen to testify in September as Novo blames U.S. health system for high ...
- Latest
- Trending
Senate subpoenas Novo's Langa over drug pricing; Jorgensen to testify in September as Novo blames U.S. health system for high ...
Oxford University's DrugGPT, an AI tool to tackle prescription issues, could revolutionize healthcare, preventing mistakes, improving compliance, and reducing expenses.
Pfizer's interest in the weight loss market is uncertain due to its significant debt of over $70 billion and recent ...
Amazon Pharmacy is leveraging AI for its same-day delivery service expansion in New York City and Los Angeles. AI helps ...
Stay updated on the latest in biotech with our newsletter and podcast. Boundless becomes the ninth biotech company to go ...
Sales of iPhones and Teslas have slumped in China, while the success of the maker of Ozempic and Wegovy is ...
Health-care companies are rallying amid expectations of higher drug prices and ongoing pharmaceutical shortages in the US. The FTC is ...
PetMed Express, a leading pet pharmacy, has received a non-compliance notice from Nasdaq for its failure to submit financial reports ...
The health care sector is witnessing a surge as drug shortages and rising prices create opportunities for growth. However, concerns ...
FDA approves Takeda's EOHILIA as first-line treatment for Eosinophilic Esophagitis. Groundbreaking oral therapy offers hope for improved quality of life.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.